TNF and Alzheimer disease: In a clinical population of AD patients, elevated baseline systemic TNF-α, when combined with an observed systemic inflammatory event (SIE), was associated with a 10-fold greater rate of cognitive decline over 6 months (Holmes et al., 2009).